MX355924B - Composicion hemostatica. - Google Patents

Composicion hemostatica.

Info

Publication number
MX355924B
MX355924B MX2014004476A MX2014004476A MX355924B MX 355924 B MX355924 B MX 355924B MX 2014004476 A MX2014004476 A MX 2014004476A MX 2014004476 A MX2014004476 A MX 2014004476A MX 355924 B MX355924 B MX 355924B
Authority
MX
Mexico
Prior art keywords
hemostatic composition
hemostasis
discloses
reactive groups
form suitable
Prior art date
Application number
MX2014004476A
Other languages
English (en)
Spanish (es)
Other versions
MX2014004476A (es
Inventor
Hoefinghoff Joris
Christian Hedrich Hans
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2014004476A publication Critical patent/MX2014004476A/es
Publication of MX355924B publication Critical patent/MX355924B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A61K38/015—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen from keratin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2014004476A 2011-10-11 2012-10-10 Composicion hemostatica. MX355924B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161545939P 2011-10-11 2011-10-11
PCT/EP2012/070054 WO2013053753A2 (en) 2011-10-11 2012-10-10 Hemostatic composition

Publications (2)

Publication Number Publication Date
MX2014004476A MX2014004476A (es) 2015-11-16
MX355924B true MX355924B (es) 2018-05-04

Family

ID=47022655

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004476A MX355924B (es) 2011-10-11 2012-10-10 Composicion hemostatica.

Country Status (11)

Country Link
US (1) US20130096062A1 (enExample)
EP (2) EP4137166A1 (enExample)
JP (2) JP6195567B2 (enExample)
KR (1) KR102143252B1 (enExample)
CN (1) CN103998068B (enExample)
AU (1) AU2012318256B2 (enExample)
CA (1) CA2851332C (enExample)
ES (1) ES2938541T3 (enExample)
IL (1) IL231962A0 (enExample)
MX (1) MX355924B (enExample)
WO (1) WO2013053753A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
EP2766058B1 (en) 2011-10-11 2022-11-23 Baxter International Inc. Hemostatic compositions
ES2938568T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
RU2678592C1 (ru) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
KR102132261B1 (ko) 2014-03-31 2020-08-06 삼성전자주식회사 비교 연산이 필요없이 최종 모듈러 감소를 하는 몽고메리 곱셈 방법 및 곱셈기
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
WO2016118043A1 (ru) * 2015-01-20 2016-07-28 Виктор Вениаминович ТЕЦ Гемостатическое средство
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
RU2602305C1 (ru) * 2015-09-30 2016-11-20 Общество с ограниченной ответственностью "Санте Фарм" Гемостатическое средство
EP3630082A4 (en) 2017-05-24 2021-12-15 Viktor Veniaminovich Tets FRACTIONED ANTIMICROBIAL COMPOSITIONS AND THEIR USE
KR101989054B1 (ko) * 2017-11-28 2019-06-13 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
EP3717028A1 (en) * 2017-11-28 2020-10-07 Baxter International Inc Wound-treating absorbent
WO2019107887A2 (ko) * 2017-11-28 2019-06-06 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US10786596B2 (en) * 2018-01-12 2020-09-29 Boston Scientific Scimed, Inc. Powder for achieving hemostasis
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법
KR102438006B1 (ko) 2020-02-25 2022-08-30 주식회사 테라시온 바이오메디칼 다용도 지혈제 조성물 및 그 제조방법
WO2021261080A1 (ja) * 2020-06-26 2021-12-30 国立研究開発法人物質・材料研究機構 多孔体、封止材、穿刺部封止装置、止血シート、及び、多孔体の製造方法
JP2023539104A (ja) * 2020-08-18 2023-09-13 ウニヴェルズィテート バーゼル 止血性エラスチン様ポリペプチド
JP2022126909A (ja) * 2021-02-19 2022-08-31 国立研究開発法人物質・材料研究機構 穿孔部閉鎖材、及び、穿孔部閉鎖材の製造方法
CN113289052B (zh) * 2021-05-14 2023-05-26 南方科技大学 一种可控交联、降解的材料及其应用
CN113599568A (zh) * 2021-08-05 2021-11-05 南方科技大学 合成材料类粉剂及其在止血体系的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US5614587A (en) * 1988-11-21 1997-03-25 Collagen Corporation Collagen-based bioadhesive compositions
US7320962B2 (en) * 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6458147B1 (en) * 1998-11-06 2002-10-01 Neomend, Inc. Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
US7279001B2 (en) * 1998-11-06 2007-10-09 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6312725B1 (en) * 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
WO2001016210A1 (en) * 1999-08-27 2001-03-08 Cohesion Technologies, Inc. Compositions that form interpenetrating polymer networks for use as high strength medical sealants
WO2003042250A1 (en) * 2001-11-15 2003-05-22 Biosyntech Canada Inc. Composition and method to homogeneously modify or cross-link chitosan under neutral conditions
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
AU2003279730A1 (en) * 2002-09-30 2004-04-19 Fibrogen, Inc. Dry tissue sealant compositions
EP1689457A2 (en) * 2003-11-10 2006-08-16 Angiotech International Ag Intravascular devices and fibrosis-inducing agents
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
DE102008005469A1 (de) * 2008-01-21 2009-07-23 Kettenbach Gmbh & Co. Kg Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung
CA2765117C (en) * 2009-06-16 2017-07-11 Joris Hoefinghoff Hemostatic sponge
ES2938568T3 (es) * 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
EP2766058B1 (en) * 2011-10-11 2022-11-23 Baxter International Inc. Hemostatic compositions

Also Published As

Publication number Publication date
AU2012318256A1 (en) 2013-05-02
JP6195567B2 (ja) 2017-09-13
CA2851332A1 (en) 2013-04-18
WO2013053753A2 (en) 2013-04-18
EP2766060A2 (en) 2014-08-20
KR102143252B1 (ko) 2020-08-11
WO2013053753A3 (en) 2013-11-07
MX2014004476A (es) 2015-11-16
CN103998068A (zh) 2014-08-20
IL231962A0 (en) 2014-05-28
US20130096062A1 (en) 2013-04-18
JP2017153975A (ja) 2017-09-07
KR20140074993A (ko) 2014-06-18
CA2851332C (en) 2020-08-25
ES2938541T3 (es) 2023-04-12
CN103998068B (zh) 2016-05-25
AU2012318256B2 (en) 2015-10-01
EP4137166A1 (en) 2023-02-22
JP2014530066A (ja) 2014-11-17
EP2766060B1 (en) 2022-11-23

Similar Documents

Publication Publication Date Title
MX2014004476A (es) Composicion hemostatica.
MX2014004475A (es) Composición hemostatica.
MX356185B (es) Composiciones hemostaticas.
IL284154A (en) Analogues of oligonucleotides containing inter-subunit bonds and/or terminal groups, preparations containing them and their uses
IL261338A (en) Preparations and methods for treating broad-spectrum, undiagnosed or mixed clinical applications
WO2011117325A3 (en) Polymer compositions comprising semi-aromatic polyamides and graphene materials
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
BR112013007286A2 (pt) composição polimérica, película e bolsa de autoclave.
EP4406557A3 (en) Materials and methods for improving gastrointestinal function
EP2389925A3 (en) Hydrogel implant with varying degrees of crosslinking
EP2643408A4 (en) COMPOSITION COMPRISING ALPHA-OLEFIN-PROPYLENE COPOLYMER, BLOCK COPOLYMER OF OLEFIN, AND DPO-BSA MOLECULAR FUSION MATERIAL
EP2389896A3 (en) Hydrogel implants with varying degrees of crosslinking
EP2835386A4 (en) COPOLYMER, RUBBER COMPOSITION THEREOF AND TIRES
ZA201302863B (en) Bioabsorbable polymeric compositions,processing methods,and medical devices therefrom
EP2889317A4 (en) ACRYLONITRILE-ACRYLATE-STYRENE-PFROPOPOPOLYMER AND THERMOPLASTIC RESIN COMPOSITION THEREWITH
WO2013173789A3 (en) Antisense oligonucleotide compositions
WO2013060769A3 (en) Hemostatic compositions
EP2389894A3 (en) Hydrogel implants with varying degrees of crosslinking
WO2013032623A3 (en) Hydrogel implants with varying degrees of crosslinking
WO2011057224A3 (en) Zwitterionic polymer bioconjugates and related methods
EP2389926A3 (en) Hydrogel implants with varying degrees of crosslinking
MY160389A (en) Higher loading zinc-containing films
WO2010145849A3 (en) Drug delivery systems
IN2014DN08301A (enExample)
PH12013501311A1 (en) Polymer systems

Legal Events

Date Code Title Description
FG Grant or registration